Reconsideration Denied In Pfizer Shareholder Class Action Lawsuit

NEW YORK - A federal judge in New York on March 22 refused to grant a motion for reconsideration filed by Pfizer Inc. and certain of its executive officers in a securities class action, ruling that the defendants have failed to provide evidence sufficient to warrant reconsideration or demonstrate a level of bad faith on the part of a shareholder "that might warrant the imposition of a terminal sanction dismissing" the shareholder's claims (In re Pfizer Inc. Securities Litigation, No. 04-9866, S.D. N.Y.; 2012 U.S. Dist. LEXIS 39449; See July 2008, Page 22). Full story on lexis.com